Yoon Sunwoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoon Sunwoo has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Anna Cho
Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea
1 shared publication - Bo Kyung Kim
Department of Pediatrics Seoul National University College of Medicine, Seoul National University Children's Hospital Seoul South Korea
1 shared publication - Byung Chan Lim
Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea
1 shared publication - Haeryung Kim
Department of Pediatrics, Seoul National University Children's Hospital, South Korea
1 shared publication - Ho-Joong Kim
Seoul National University College of Medicine
1 shared publication - Hyoung Jin Kang
Department of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 12 (3) , e200364
Expanding the Clinical Spectrum of Arboleda-Tham Syndrome
Background and ObjectivesArboleda-Tham syndrome (ARTHS) is a rare autosomal dominant neurodevelopmental disorder caused by pathogenic variants in the lysine acetyltransferase 6A (KAT6A) gene, chara...
- 1 June 2026
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 12 (3) , e200364
Open AccessExpanding the Clinical Spectrum of Arboleda-Tham Syndrome
Background and ObjectivesArboleda-Tham syndrome (ARTHS) is a rare autosomal dominant neurodevelopmental disorder caused by pathogenic variants in the lysine acetyltransferase 6A (KAT6A) gene, chara...
- Open Access
- 13 May 2025
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (5) , 2693-2706
Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome
Inherited bone marrow failure syndromes are genetic hematologic disorders with increased cancer risk. Accurate diagnosis is crucial for appropriate management. This study assessed the clinical usefulness of next-generation sequencing (NGS)-based target gene sequencing in pediatric and AYA (adolescent and young adult) patients with hematologic abnormalities. From December 2019 to June 2023, 93 patients with suspected congenital hematologic diseases at a single institution underwent NGS-based testing. Medical records were retrospectively reviewed. The median age at diagnosis was 9.3 years (range 0.2–31.4), with 59.1% males. Indications for testing included specific medical histories (28 patients), persistent cytopenia or recurrent neutropenic fever (22 patients), changes in cytopenia patterns (11 patients), and other reasons (32 patients). Pathogenic variants were identified in 9/28 (32.1%), 3/22 (13.6%), 4/11 (36.4%), and 0/32 (0%). Overall, 16 patients (17.2%) had pathogenic variants, including FANCA, BRCA2, PMS2, ELANE, G6PC3 and VPS13B in patients with idiopathic neutropenia, and GATA2 in patients with suspected myelodysplastic syndrome. Genetic findings led to diagnostic revisions in 12 patients (12.9%), including reclassification of aplastic anemia (AA) as Fanconi anemia, Diamond-Blackfan anemia, or Shwachman-Diamond syndrome, prompting hematopoietic stem cell transplantation and altering cancer surveillance. Pathogenic variants were more frequently observed in patients with a specific medical history or changes in cytopenia, and in those with additional clinical features (cytogenetic abnormalities or non-severe AA). This study demonstrated the diagnostic usefulness of NGS-based target gene sequencing for pediatric and AYA patients with suspected genetic hematologic disorders, supporting the need for multicenter studies and standardized guideline development.
- 13 May 2025
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (5) , 2693-2706
Open AccessClinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome
Inherited bone marrow failure syndromes are genetic hematologic disorders with increased cancer risk. Accurate diagnosis is crucial for appropriate management. This study assessed the clinical usefulness of next-generation sequencing (NGS)-based target gene sequencing in pediatric and AYA (adolescent and young adult) patients with hematologic abnormalities. From December 2019 to June 2023, 93 patients with suspected congenital hematologic diseases at a single institution underwent NGS-based testing. Medical records were retrospectively reviewed. The median age at diagnosis was 9.3 years (range 0.2–31.4), with 59.1% males. Indications for testing included specific medical histories (28 patients), persistent cytopenia or recurrent neutropenic fever (22 patients), changes in cytopenia patterns (11 patients), and other reasons (32 patients). Pathogenic variants were identified in 9/28 (32.1%), 3/22 (13.6%), 4/11 (36.4%), and 0/32 (0%). Overall, 16 patients (17.2%) had pathogenic variants, including FANCA, BRCA2, PMS2, ELANE, G6PC3 and VPS13B in patients with idiopathic neutropenia, and GATA2 in patients with suspected myelodysplastic syndrome. Genetic findings led to diagnostic revisions in 12 patients (12.9%), including reclassification of aplastic anemia (AA) as Fanconi anemia, Diamond-Blackfan anemia, or Shwachman-Diamond syndrome, prompting hematopoietic stem cell transplantation and altering cancer surveillance. Pathogenic variants were more frequently observed in patients with a specific medical history or changes in cytopenia, and in those with additional clinical features (cytogenetic abnormalities or non-severe AA). This study demonstrated the diagnostic usefulness of NGS-based target gene sequencing for pediatric and AYA patients with suspected genetic hematologic disorders, supporting the need for multicenter studies and standardized guideline development.
- Open Access
- 31 December 2022
- Published by Korean Society of Medical Genetics in Journal of Genetic Medicine
- Vol. 19 (2) , 111-114
Variant of CHD1 gene resulting in a Korean case of Pilarowski-Bjornsson syndrome
Yoon Sunwoo, Soo Hyun Seo, Ho-Joong Kim, Moon Seok Park, and Anna Cho. J Genet Med 2022;19:111-4. https://doi.org/10.5734/JGM.2022.19.2.111
- 31 December 2022
- Published by Korean Society of Medical Genetics in Journal of Genetic Medicine
- Vol. 19 (2) , 111-114
Open AccessVariant of CHD1 gene resulting in a Korean case of Pilarowski-Bjornsson syndrome
Yoon Sunwoo, Soo Hyun Seo, Ho-Joong Kim, Moon Seok Park, and Anna Cho. J Genet Med 2022;19:111-4. https://doi.org/10.5734/JGM.2022.19.2.111